ETF Managers Group’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-21,560
Closed -$367K 755
2021
Q3
$367K Sell
21,560
-1,484
-6% -$23.5K 0.01% 578
2021
Q2
$367K Sell
23,044
-16,648
-42% -$301K 0.01% 572
2021
Q1
$735K Buy
39,692
+7,089
+22% +$151K 0.01% 323
2020
Q4
$590K Buy
32,603
+3,919
+14% +$82.1K 0.01% 306
2020
Q3
$554K Buy
28,684
+2,230
+8% +$50.5K 0.02% 289
2020
Q2
$673K Buy
26,454
+2,864
+12% +$70K 0.02% 233
2020
Q1
$428K Buy
23,590
+2,096
+10% +$56.6K 0.02% 230
2019
Q4
$731K Buy
21,494
+1,638
+8% +$44.7K 0.03% 222
2019
Q3
$476K Buy
19,856
+2,161
+12% +$70.6K 0.02% 265
2019
Q2
$583K Buy
17,695
+5,985
+51% +$221K 0.02% 239
2019
Q1
$433K Sell
11,710
-377
-3% -$15.8K 0.02% 243
2018
Q4
$520K Buy
12,087
+1,541
+15% +$69.3K 0.02% 225
2018
Q3
$498K Buy
+10,546
New +$490K 0.02% 222
2018
Q2
Sell
-8,161
Closed -$395K 592
2018
Q1
$395K Buy
8,161
+1,316
+19% +$65.9K 0.02% 218
2017
Q4
$264K Buy
+6,845
New +$244K 0.02% 208

Other funds holding URGN